Baruch S. Blumberg Institute launches MERLIN Biotech, a spinout company leveraging mRNA technology for therapeutics and vaccines <<click here>> 

Investment Opportunities

If you’re interested in investment opportunities with PABC member companies and/or the HatchBio Fund, please complete/submit this form.

Alternatively, you can email louis.kassa@pabiotechbc.org